SCHEMBL6707767

SCHEMBL6707767

N#Cc1ccc(NC(=O)c2noc3ccc([N+](=O)[O-])cc23)c(-c2noc(=O)[nH]2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 4/20 0.42
LMNA P02545 3/20 0.39
CYP1A2 P05177 2/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
HTT P42858 2/20 0.33
MAPT P10636 3/20 0.33
ALDH1A1 P00352 2/20 0.33
NPC1 O15118 2/20 0.33
MAOB P27338 2/20 0.33
F12 P00748 1/20 0.33
PYGL P06737 1/20 0.33
AURKA O14965 1/20 0.32
PDPK1 O15530 1/20 0.32
JAK2 O60674 1/20 0.32
GMNN O75496 1/20 0.32
EGFR P00533 1/20 0.32
TP53 P04637 1/20 0.32
LYN P07948 1/20 0.32
CHRM2 P08172 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6921608 0.89 HIF1A (0.38) HIF1ALMNACYP1A2MEN1KMT2A
SCHEMBL6708868 0.87 HIF1A (0.44) HIF1ALMNACYP1A2MEN1KMT2A
SCHEMBL6710550 0.87 HIF1A (0.44) HIF1ALMNACYP1A2MEN1KMT2A
SCHEMBL6709076 0.86 LMNA (0.35) HIF1ALMNACYP1A2MEN1KMT2A
SCHEMBL6707723 0.86 GRIK1 (0.39) HIF1AMEN1KMT2AHTTMAPT
SCHEMBL6711761 0.86 HIF1A (0.34) HIF1AMAPTTP53
SCHEMBL6710262 0.86 HIF1A (0.42) HIF1ALMNACYP1A2MEN1KMT2A
SCHEMBL6714271 0.85 HIF1A (0.48) HIF1A
SCHEMBL6707777 0.84 HIF1A (0.38) HIF1AMAPTTP53
SCHEMBL6713809 0.84 HIF1A (0.43) HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 HIF1A 296/4885LMNA 4062/4885CYP1A2 492/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.